DarioHealth Corp.
DRIO
$11.94
-$0.03-0.25%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 24.73M | 27.15M | 28.03M | 27.04M | 23.05M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 24.73M | 27.15M | 28.03M | 27.04M | 23.05M |
| Cost of Revenue | 7.89M | 8.28M | 8.58M | 8.75M | 9.01M |
| Gross Profit | 16.84M | 18.87M | 19.46M | 18.30M | 14.04M |
| SG&A Expenses | 36.66M | 37.95M | 41.64M | 46.10M | 46.27M |
| Depreciation & Amortization | 2.78M | 3.94M | 4.74M | 5.03M | 4.85M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 63.76M | 68.73M | 76.60M | 84.06M | 83.22M |
| Operating Income | -39.03M | -41.58M | -48.57M | -57.02M | -60.16M |
| Income Before Tax | -42.14M | -44.02M | -44.64M | -44.60M | -49.34M |
| Income Tax Expenses | 177.00K | 164.00K | 164.00K | -1.85M | -1.94M |
| Earnings from Continuing Operations | -42.32 | -44.18 | -44.80 | -42.75 | -47.40 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -42.32M | -44.18M | -44.80M | -42.75M | -47.40M |
| EBIT | -39.03M | -41.58M | -48.57M | -57.02M | -60.16M |
| EBITDA | -33.87M | -34.84M | -40.79M | -49.17M | -53.55M |
| EPS Basic | -11.85 | -13.80 | -11.95 | -13.10 | -18.92 |
| Normalized Basic EPS | -9.17 | -10.90 | -11.90 | -12.80 | -17.51 |
| EPS Diluted | -11.85 | -13.80 | -11.95 | -13.10 | -18.92 |
| Normalized Diluted EPS | -9.17 | -10.90 | -11.90 | -12.80 | -17.51 |
| Average Basic Shares Outstanding | 11.93M | 10.81M | 10.32M | 9.68M | 7.18M |
| Average Diluted Shares Outstanding | 11.93M | 10.81M | 10.32M | 9.68M | 7.18M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |